Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions
about
Gene-based therapy of Parkinson's Disease: Translation from animal model to human clinical trial employing convection enhanced deliveryRapid inverse planning for pressure-driven drug infusions in the brainAutomated segmentation tool for brain infusionsMRI-based computational model of heterogeneous tracer transport following local infusion into a mouse hind limb tumorPhase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.Effect of imaging and catheter characteristics on clinical outcome for patients in the PRECISE studyImage-guided convection-enhanced delivery platform in the treatment of neurological diseases.Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumorsAnatomical differences determine distribution of adenovirus after convection-enhanced delivery to the rat brain.Image-guided convection-enhanced delivery into agarose gel models of the brainConvection-enhanced delivery of free gadolinium with the recombinant immunotoxin MR1-1.Magnetic resonance imaging properties of convective delivery in diffuse intrinsic pontine gliomas.Convection-enhanced delivery of camptothecin-loaded polymer nanoparticles for treatment of intracranial tumorsColocalization of gadolinium-diethylene triamine pentaacetic acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humans.Convection-enhanced drug delivery of interleukin-4 Pseudomonas exotoxin (PRX321): increased distribution and magnetic resonance monitoring.Predictive models for pressure-driven fluid infusions into brain parenchyma.Immunotherapy of malignant brain tumors.Jeannette Wilkins Award: Can locally delivered gadolinium be visualized on MRI? A pilot study.Evaluation of pressure-driven brain infusions in nonhuman primates by intra-operative 7 Tesla MRI.Spatiotemporal quantification of local drug delivery using MRI.Convection-enhanced delivery for the treatment of brain tumors.Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.Voxelized computational model for convection-enhanced delivery in the rat ventral hippocampus: comparison with in vivo MR experimental studies.Detection of infusate leakage in the brain using real-time imaging of convection-enhanced delivery.Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience.Voxelized Model of Brain Infusion That Accounts for Small Feature Fissures: Comparison With Magnetic Resonance Tracer StudiesConvection-enhanced delivery in the treatment of epilepsy.Targeted drug delivery for treatment and imaging of glioblastoma multiforme.Future of convection-enhanced delivery in the treatment of brain tumors.Molecular neurosurgery: vectors and vector delivery strategies.Diphtheria toxin-based targeted toxin therapy for brain tumors.Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics.Convection-Enhanced Delivery.Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment.Current status of intratumoral therapy for glioblastoma.Interstitial chemotherapy for malignant glioma: Future prospects in the era of multimodal therapyA novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Rα2 tumor-restricted biomarker.Delivering therapy to target: improving the odds for successful drug development.Analysis of a simulation algorithm for direct brain drug delivery.Convection-enhanced drug delivery for gliomas.
P2860
Q26851517-CAA99BD1-500D-4746-8CFD-4316E7C69ACDQ28486200-F2397A1A-2E91-494C-9D8B-3CC16A015281Q28533650-FE0FEB9F-AA55-4651-B8F9-FD217A0DA865Q28540719-6CDB366B-B53F-4DE6-A546-5BA086B53BFBQ30431291-DF38E5C9-07BC-4A37-BB51-7E38EE1C8280Q30433568-B0C981D0-0DAB-4025-AED5-EB5AC47DB27CQ31141544-4482BE4A-1508-400A-B1B1-FB193097511AQ33697847-7A7D19E6-529C-4F24-A92F-71D9B9DFA88BQ34055421-EFAE895F-8F83-4F57-AF97-03130193644BQ34292447-D1293C28-F864-4879-8732-14FF2884F4C7Q34856189-CA3A4418-2A19-4CBF-8D7D-AB149A4CEA10Q34954842-495AC7F9-CDBB-46FD-86DE-FA9A5F0A23A9Q35052416-61B65E4B-A47D-40AF-8A4D-B0D2B558654EQ35159477-A22677CC-8A12-4850-8453-E875D508000FQ35453991-BAFAB901-AA6F-4B5A-A491-47605EF0AB69Q35645959-0428C037-DFE1-44B6-ACC3-D74D1BB43CE2Q36162929-2D2065B9-6882-487C-84C2-47E9C724B2EEQ36233353-4BD7D9D3-D2F8-498E-B427-3659FAD6B143Q36433585-BDE20E91-CBAC-4212-80C0-E5E381BE2DD7Q36848242-2F96C1CE-C579-49C8-97D1-E5A810140A3EQ36854365-1F6FB553-935A-42A0-8348-28548B3667F6Q36926763-A3C2AA9F-548A-4A71-924A-C075E5BBCD61Q37061585-E36065BC-DD0C-4A75-877E-D2D496061751Q37301009-14C11825-D6E0-4A81-A21D-FF13E6E4C8FAQ37380284-016A33BB-3318-4BBE-8C0E-85E1D1374D7AQ37401832-779FBB4F-AC8D-4CA4-A7E9-3AA48EEDBC01Q37426998-7674578E-1512-44B9-96EE-DD1728FC7082Q37523966-54008531-4805-4054-BDA7-980DA7F58C20Q37658777-1C312040-2EE4-481A-A031-D8CA13FF96D1Q37998570-766363B9-0443-466C-9BD7-6A94BC6F5E66Q38108516-3B0B41BA-C699-454A-B20A-C0EA8021CD8DQ38535624-636BDE97-9025-44F2-BDB8-381277D88BCCQ38744447-D4366F5B-5AA5-484C-962C-8CCA4ED3CE00Q38852756-26F3DB7B-B2E6-4103-BABB-218C3392FCF8Q38978737-468D28E8-6B99-4820-A7B8-99C2013E94CEQ39034877-D8C62C35-3D99-4318-AB76-EBD8D868B193Q39284797-91A0338F-A19B-4274-A7BE-9C9AABC878C5Q39610770-8A12C60F-E29C-4BEA-A0E5-AB1FE997F34DQ40281618-B5667399-3EBE-4257-82D4-90073DDD4792Q43159976-B0610CEB-CA78-4607-BB4B-AA3A13F00C7F
P2860
Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Clinical utility of a patient- ...... g intracerebral drug infusions
@ast
Clinical utility of a patient- ...... g intracerebral drug infusions
@en
type
label
Clinical utility of a patient- ...... g intracerebral drug infusions
@ast
Clinical utility of a patient- ...... g intracerebral drug infusions
@en
prefLabel
Clinical utility of a patient- ...... g intracerebral drug infusions
@ast
Clinical utility of a patient- ...... g intracerebral drug infusions
@en
P2093
P2860
P50
P1433
P1476
Clinical utility of a patient- ...... g intracerebral drug infusions
@en
P2093
Christoph Pedain
David Croteau
Ira Pastan
James E Herndon
James M Provenzale
John H Sampson
Martin L Brady
María Inmaculada Rodríguez-Ponce
Philipp Tanner
R Edward Coleman
P2860
P304
P356
10.1215/15228517-2007-007
P577
2007-04-13T00:00:00Z